Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Endocrinol (Oxf). 2011 Nov;75(5):715-21. doi: 10.1111/j.1365-2265.2011.04156.x.
To investigate thyroid-stimulating hormone receptor (TSHR) and thyroid peroxidase (TPO) mutations in Korean patients with primary congenital hypothyroidism (CH).
Congenital hypothyroidism is a common genetic disorder in which the majority of mutations occur in the TSHR and TPO genes.
We examined the frequencies of TSHR and TPO mutations among Korean patients with primary CH. Furthermore, we explored the relationships between imaging findings and mutation status.
A total of 193 paediatric patients with nonsyndromic CH were enrolled in the present study.
Patients with decreased (99m) Tc uptake were screened for TSHR mutations using Sanger sequencing, and those with increased uptake were screened for TPO mutations. The relationships between scintigraphic and ultrasonographic findings and mutation status were analysed.
Thirteen (16·5%) of 79 patients with decreased (99m) Tc uptake were found to harbour TSHR mutations including G132R, G245S, R450H, R519C and F525S. The R450H mutation was present in 13 (72·2%) of 18 disease alleles. Seven (10·3%) of 68 patients with increased (99m) Tc uptake harboured TPO mutations including R189Q, K439E, G493S, C808LfsX72, A863T, R875Hfs and P883S. The TSHR and TPO mutations were observed only in patients with normal to slightly enlarged thyroid glands.
This study identified underlying TSHR and TPO mutations in Korean patients with CH and revealed a possible relationship between imaging findings and mutation status. In addition, the low rate of mutation positivity suggests significant genetic heterogeneity of CH in the Korean population.
研究韩国原发性先天性甲状腺功能减退症(CH)患者的促甲状腺激素受体(TSHR)和甲状腺过氧化物酶(TPO)突变。
先天性甲状腺功能减退症是一种常见的遗传疾病,其中大多数突变发生在 TSHR 和 TPO 基因中。
我们检查了韩国原发性 CH 患者 TSHR 和 TPO 突变的频率。此外,我们还探讨了影像学发现与突变状态之间的关系。
共纳入 193 例非综合征性 CH 儿科患者。
采用 Sanger 测序法对(99m)Tc 摄取减少的患者进行 TSHR 突变筛查,对摄取增加的患者进行 TPO 突变筛查。分析了闪烁显像和超声检查结果与突变状态之间的关系。
在 79 例(99m)Tc 摄取减少的患者中,有 13 例(16.5%)发现 TSHR 突变,包括 G132R、G245S、R450H、R519C 和 F525S。R450H 突变存在于 18 个疾病等位基因中的 13 个(72.2%)。在 68 例(99m)Tc 摄取增加的患者中,有 7 例(10.3%)发现 TPO 突变,包括 R189Q、K439E、G493S、C808LfsX72、A863T、R875Hfs 和 P883S。TSHR 和 TPO 突变仅见于甲状腺正常或轻度肿大的患者。
本研究鉴定了韩国 CH 患者的 TSHR 和 TPO 突变,并揭示了影像学发现与突变状态之间的可能关系。此外,突变阳性率低提示韩国人群 CH 的遗传异质性较大。